Holen Sie sich die Stockscreener-App
30.51
0.69%
0.21
Handel nachbörslich:
30.67
0.16
+0.52%
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Farther Finance Advisors LLC Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Assenagon Asset Management S.A. Sells 47,897 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Rhumbline Advisers Grows Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
How the (COLL) price action is used to our Advantage - news.stocktradersdaily.com
California State Teachers Retirement System Sells 856 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities - Yahoo Finance
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers - Yahoo Finance
Bank of America Corp DE Reduces Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Two Sigma Investments LP Sells 135,582 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
ProShare Advisors LLC Increases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Millennium Management LLC Raises Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ameriprise Financial Inc. - Defense World
Deutsche Bank AG Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Jane Street Group LLC Sells 20,543 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.80 - Defense World
Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
Collegium Pharmaceutical Approves 2025 Equity Incentive Plan - TipRanks
Collegium Pharmaceutical, Inc. to Present at Mizuho Neuro & Ophthalmology Summit and Jefferies Global Healthcare Conference - Nasdaq
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical to Present at Mizuho Neuro Summit and Jefferies Healthcare Conference - Stock Titan
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Comerica Bank - Defense World
There May Be Reason For Hope In Collegium Pharmaceutical's (NASDAQ:COLL) Disappointing Earnings - simplywall.st
Voya Investment Management LLC Sells 789 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) Initiates $25 Million Share Repu - GuruFocus
Collegium Pharmaceutical buys back $25 million in shares By Investing.com - Investing.com Canada
Collegium Pharmaceutical initiates $25M share buyback By Investing.com - Investing.com Canada
Collegium Pharmaceutical Signs $25 Million Accelerated Share Buyback Deal With Jefferies - marketscreener.com
Collegium Announces $25 Million Accelerated Share Repurchase Program - marketscreener.com
Collegium Pharmaceutical initiates $25M share buyback - Investing.com
Collegium Pharmaceutical enters into accelerated share repurchase agreement - MSN
Collegium Pharmaceutical Announces Share Repurchase Agreement - TipRanks
Collegium Pharmaceutical buys back $25 million in shares - Investing.com Australia
Collegium Pharmaceutical Announces $25 Million Accelerated Share Repurchase Agreement with Jefferies LLC - Nasdaq
Collegium pharmaceutical targets $135M in Jornay PM revenue for 2025 amid sales force expansion - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap Up – Time to Buy? - Defense World
(COLL) Proactive Strategies - news.stocktradersdaily.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2025 Earnings Call Transcript - Insider Monkey
Collegium Pharmaceutical (COLL) Sees Price Target Increase by Pi - GuruFocus
COLL Reaffirms FY25 Adjusted EBITDA Outlook and Highlights Strat - GuruFocus
Collegium Pharmaceutical’s Earnings Call Highlights Growth and Strategic Initiatives - TipRanks
Collegium Pharmaceutical (COLL) Price Target Increased by Piper Sandler | COLL Stock News - GuruFocus
Earnings call transcript: Collegium Pharmaceutical sees strong Q1 2025 growth - Investing.com India
Pacer Advisors, Inc. Reduces Stake in Collegium Pharmaceutical I - GuruFocus
Collegium Pharmaceutical Q1 2025 Earnings Call Transcript - MarketBeat
Collegium Pharmaceutical Inc (COLL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada
Collegium Pharmaceutical Reports Strong Q1 2025 Growth - TipRanks
Collegium Pharmaceutical: Q1 Earnings Snapshot - New Haven Register
Collegium Pharmaceutical, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:COLL) - Seeking Alpha
2.01%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):